Fulgent Genetics, Inc. FLGT Therapeutic Development — Intangible Assets Net Excluding Goodwill
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Fulgent Genetics, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s therapeutic development — intangible assets net excluding goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s therapeutic development — intangible assets net excluding goodwill?
- Fulgent Genetics, Inc. (FLGT) reported therapeutic development — intangible assets net excluding goodwill of $70.73M in Q4 2025.
- What does therapeutic development — intangible assets net excluding goodwill mean?
- The aggregate net carrying value of all identifiable intangible assets, both finite and indefinite-lived, held by the therapeutic development segment. This metric provides a consolidated view of the segment's non-physical competitive advantages.